SUPERIOR EFFICACY OF COMBINATION PHARMACOTHERAPY FOR TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY

被引:0
|
作者
Fraser, M. O. [1 ]
Lloyd, J. C. [2 ]
Le, N. [2 ]
Wiener, J. S. [2 ]
Dolber, P. C. [3 ]
机构
[1] Duke Univ, Med Ctr, Inst Med Res, Durham VAMC, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Duke Univ, Med Ctr, Durham VAMC, Durham, NC USA
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OP 020
引用
收藏
页码:S95 / S96
页数:2
相关论文
共 50 条
  • [41] Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder
    Watanabe, Miho
    Yamanishi, Tomonori
    Honda, Mikihiko
    Sakakibara, Ryuji
    Uchiyama, Tomoyuki
    Yoshida, Ken-Ichiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 (11) : 931 - 936
  • [42] Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics
    H Madersbacher
    G Mürtz
    M Stöhrer
    Spinal Cord, 2013, 51 : 432 - 441
  • [43] PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY TREATED WITH ONABOTULINUMTOXINA ACHIEVE THEIR TREATMENT GOALS
    Rovner, Eric
    Chancellor, Michael
    Corbell, Catherine
    Ni, Quanhong
    Globe, Denise
    Chartier-Kastler, Emmanual
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 177 - 178
  • [44] Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application
    Giannantoni, Antonella
    Mearini, Ettore
    Del Zingaro, Michele
    Santaniello, Francesco
    Porena, Massimo
    BJU INTERNATIONAL, 2008, 102 : 2 - 6
  • [45] Treatment of Neurogenic Detrusor Overactivity with Botulinum Toxin A: The First Seven Years
    Stoehrer, Manfred
    Wolff, Andreas
    Kramer, Guus
    Steiner, Rainer
    Loechner-Ernst, Dieter
    Leuth, Dirk
    Steude, Ute
    Ruebben, Herbert
    UROLOGIA INTERNATIONALIS, 2009, 83 (04) : 379 - 385
  • [46] The Botulinum Treatment of Neurogenic Detrusor Overactivity: The Double-Face of the Neurotoxin
    Traini, Chiara
    Vannucchi, Maria Giuliana
    TOXINS, 2019, 11 (11)
  • [47] NEUROGENIC DETRUSOR OVERACTIVITY IN ADULTS: A REVIEW OF THE EFFICACY, TOLERABILITY AND SAFETY OF ORAL ANTIMUSCARINICS
    Stoehrer, M.
    Muertz, G.
    Madersbacher, H.
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (06) : 1088 - 1089
  • [48] Neurogenic detrusor overactivity in adults: a review on efficacy, tolerability and safety of oral antimuscarinics
    Madersbacher, H.
    Muertz, G.
    Stoehrer, M.
    SPINAL CORD, 2013, 51 (06) : 432 - 441
  • [49] NEUROGENIC DETRUSOR OVERACTIVITY IN ADULTS: A REVIEW OF THE EFFICACY, TOLERABILITY AND SAFETY OF ORAL ANTIMUSCARINICS
    Stohrer, M.
    Muertz, G.
    Madersbacher, H.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2010, 21 : S284 - S285
  • [50] Noninferiority of incobotulinumtoxin a compared to onabotulinumtoxin a in the treatment of idiopathic and neurogenic detrusor overactivity
    Gubbiotti, Marilena
    Rubilotta, Emanuele
    Balzarro, Matteo
    Bini, Vittorio
    Giannantoni, Antonella
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S61 - S62